{"text": ["Merck", "(MRK)", "Presents", "New", "Data", "from", "Januvia", "Diabetes", "Studies"], "created_at": "2018-06-25 18:07:58"}
{"text": ["Merck", "(MRK)", "Presents", "New", "Data", "from", "Januvia", "Diabetes", "Studies"], "created_at": "2018-06-25 18:07:58"}
{"text": ["Lilly", "Wins", "Favorable", "Ruling", "From", "U.S.", "Court", "in", "Alimta", "Row"], "created_at": "2018-06-25 17:09:21"}
{"text": ["Lilly", "Wins", "Favorable", "Ruling", "From", "U.S.", "Court", "in", "Alimta", "Row"], "created_at": "2018-06-25 17:09:21"}
{"text": ["Lilly", "Wins", "Favorable", "Ruling", "From", "U.S.", "Court", "in", "Alimta", "Row"], "created_at": "2018-06-25 15:23:03"}
{"text": ["Lilly's", "Jardiance", "meets", "main", "goal", "of", "two", "diabetes", "trials"], "created_at": "2018-06-25 12:39:51"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "And", "Co."], "created_at": "2018-06-25 12:01:14"}
{"text": ["Boehringer", "Ingelheim", "and", "Lilly", "announce", "positive", "top-line", "Phase", "III", "data", "results", "for", "empagliflozin", "as", "adjunct", "to", "insulin", "in", "type", "1", "diabetes"], "created_at": "2018-06-25 12:00:00"}
{"text": ["First-ever", "Study", "of", "Lilly's", "Humulin\u00ae", "R", "U-500", "Administered", "in", "an", "Insulin", "Pump", "Shows", "Improved", "A1C", "in", "People", "with", "Type", "2", "Diabetes"], "created_at": "2018-06-25 12:00:00"}
{"text": ["Lilly", "to", "Present", "Phase", "3", "Data", "at", "AHS", "2018", "Highlighting", "Innovative", "Potential", "Treatments", "for", "Migraine", "and", "Cluster", "Headache"], "created_at": "2018-06-25 10:45:00"}
{"text": ["Eli", "Lilly:", "Humulin", "R", "U-500", "Administered", "In", "Insulin", "Pump", "Shows", "Improved", "A1C"], "created_at": "2018-06-25 08:51:00"}
{"text": ["Eli", "Lilly:", "Humulin", "R", "U-500", "Administered", "In", "Insulin", "Pump", "Shows", "Improved", "A1C"], "created_at": "2018-06-25 08:51:00"}
{"text": ["Boehringer", "Ingelheim", "&", "Eli", "Lilly:", "Empagliflozin", "Trials", "Meet", "Primary", "Endpoint"], "created_at": "2018-06-25 08:19:00"}
{"text": ["Boehringer", "Ingelheim", "&", "Eli", "Lilly:", "Empagliflozin", "Trials", "Meet", "Primary", "Endpoint"], "created_at": "2018-06-25 08:19:00"}
{"text": ["Eli", "Lilly", "To", "Present", "Phase", "3", "Data", "For", "Galcanezumab,", "Lasmiditan", "-", "Quick", "Facts"], "created_at": "2018-06-25 06:59:00"}
{"text": ["Eli", "Lilly", "To", "Present", "Phase", "3", "Data", "For", "Galcanezumab,", "Lasmiditan", "-", "Quick", "Facts"], "created_at": "2018-06-25 06:59:00"}
